Electrophysiology Devices Market Size, Share, Growth and Global Industry Analysis
商品番号 : SMB-77965
| 出版社 | Fortune Business Insights |
| 出版年月 | 2025年5月 |
| ページ数 | 140 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,850 |
| 種別 | 英文調査報告書 |
技術革新は、電気生理学（EP）デバイス市場にとって依然として重要な推進力となっています。3Dマッピングシステム、接触力感知カテーテル、ロボット支援電気生理学などの進歩は、不整脈の診断と治療の方法を変革しました。これらの革新により、精度の向上、処置時間の短縮、そして患者転帰の改善が実現しました。アボットやメドトロニックといった企業は、TactiCathコンタクトフォースアブレーションカテーテルやEnSite精密マッピングシステムなどの製品で、この分野をリードしています。
Growth Factors of Electrophysiology Devices Market
The global Electrophysiology (EP) devices market has been undergoing significant transformation, fueled by advancements in medical technology, the increasing prevalence of cardiovascular diseases, and an expanding geriatric population. EP devices are essential tools in diagnosing and treating electrical disorders of the heart, including arrhythmias like atrial fibrillation and ventricular tachycardia. The market is expected to grow substantially over the coming years, driven by technological advancements and rising awareness of heart health globally.
世界の電気生理（EP）デバイス市場は、医療技術の進歩、心血管疾患の罹患率の増加、そして高齢化人口の増加を背景に、大きな変革期を迎えています。EP機器は、心房細動や心室頻拍といった不整脈を含む心臓の電気的疾患の診断と治療に不可欠なツールです。この市場は、技術の進歩と世界的な心臓の健康に対する意識の高まりを背景に、今後数年間で大幅に成長すると予想されています。
Market Overview
The global electrophysiology devices market was valued at USD 7.12 billion in 2024, with projections to reach USD 16.33 billion by 2032, reflecting a compound annual growth rate (CAGR) of 10.8% from 2024 to 2032. This growth is largely attributed to an increasing incidence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and technological advancements in electrophysiological treatments. A growing aging population and the increasing frequency of lifestyle-related diseases, such as hypertension and diabetes, further contribute to the demand for EP devices.
Geographical Insights
The North American market for electrophysiology devices holds a dominant position, accounting for 34.69% of the market share in 2024. The region’s dominance can be attributed to a high rate of cardiovascular diseases, robust healthcare infrastructure, and favorable reimbursement policies that promote the adoption of advanced medical technologies. Additionally, the presence of key players such as Abbott, Medtronic, and Boston Scientific enhances the growth prospects of the North American market.
In contrast, the Asia Pacific region is expected to witness the fastest growth during the forecast period. Countries like China and India are experiencing rapid urbanization, improved healthcare infrastructure, and increasing healthcare awareness, leading to a greater demand for advanced diagnostic and treatment tools. India, in particular, is projected to grow at a CAGR of 16.1%, driven by government initiatives, a rising middle class, and a significant shift toward preventive healthcare.
Market Segmentation
The electrophysiology devices market can be segmented based on product type, application, and end user.
By Product Type
EP devices are primarily categorized into ablation catheters, diagnostic catheters, and EP monitoring systems. Of these, ablation catheters have historically dominated the market and are expected to continue leading the growth trajectory. These catheters are used to treat arrhythmias by delivering radiofrequency energy to specific areas of the heart. The rising prevalence of atrial fibrillation (AFib) and the increased adoption of catheter-based procedures are key factors driving this segment.
Diagnostic catheters, which help in mapping and assessing heart arrhythmias, are also expected to see significant growth. The development of high-definition mapping systems and advancements in catheter technology contribute to the segment’s growth. EP monitoring systems, which enable real-time observation of the heart’s electrical activity, also play a crucial role in diagnostic procedures.
By Application
The market can also be segmented based on the application of EP devices, including supraventricular tachycardia (SVT), ventricular tachycardia (VT), atrial fibrillation (AFib), and others. Among these, supraventricular tachycardia is the leading application segment. The rising incidence of arrhythmias and the effectiveness of catheter ablation procedures in treating SVT are major factors driving this segment.
By End User
Hospitals and ambulatory surgical centers (ASCs) are the primary end users of electrophysiology devices. These settings account for a large share of market demand due to the high volume of cardiac procedures performed. Hospitals are equipped with advanced EP labs that support complex diagnostic and therapeutic interventions.
Technological Advancements and Market Trends
Technological innovation remains a critical driver for the EP devices market. Advancements such as 3D mapping systems, contact force-sensing catheters, and robot-assisted electrophysiology have transformed the way arrhythmias are diagnosed and treated. These innovations enable greater precision, reduced procedure times, and improved patient outcomes. Companies like Abbott and Medtronic are leading the charge with products like the TactiCath Contact Force Ablation Catheter and the EnSite Precision Mapping System.
The global focus on minimally invasive surgeries and patient-centric care has further boosted the demand for EP devices. These procedures offer faster recovery times and fewer complications compared to traditional open-heart surgeries, making them the preferred choice for treating arrhythmias.
Challenges and Opportunities
Despite the market’s positive outlook, the electrophysiology devices sector faces challenges such as high procedural costs and limited access to advanced treatment options in low-income regions. However, these challenges present significant opportunities for market expansion, particularly in emerging markets where healthcare infrastructure is rapidly evolving.
Conclusion
The electrophysiology devices market is poised for impressive growth over the next decade, driven by technological advancements, the increasing burden of cardiovascular diseases, and growing awareness of heart health. With major industry players investing in innovation and expanding into new regions, the future of EP devices looks bright, offering opportunities for both established companies and newcomers in the field.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Unit Value (USD billion)
Segmentation
By Type
- Ablation Catheters
- Diagnostic Catheters
- Mapping System
- Accessories
- Others
By Application
- Atrial Fibrillation
- Supraventricular Tachycardia (SVT)
- Ventricular Tachycardia
- Others
By End User
- Hospitals & ASCs
- Specialty Clinics & Diagnostic Centers
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. New Product Launches by Key Market Players
4.2. Prevalence of Tachycardia by Key Regions/ Key Countries, 2024
4.3. Technological Advancements in Electrophysiology Devices
4.4. Key industry Developments – Mergers, Acquisitions and Partnerships
4.5. Impact of COVID-19 on Electrophysiology Devices Market
5. Global Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Ablation Catheters
5.2.2. Diagnostic Catheters
5.2.3. Mapping System
5.2.4. Accessories
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Atrial Fibrillation
5.3.2. Supraventricular Tachycardia (SVT)
5.3.3. Ventricular Tachycardia
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals & ASC’s
5.4.2. Specialty Clinics & Diagnostic Centers
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Type
6.2.1. Ablation Catheters
6.2.2. Diagnostic Catheters
6.2.3. Mapping System
6.2.4. Accessories
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1. Atrial Fibrillation
6.3.2. Supraventricular Tachycardia (SVT)
6.3.3. Ventricular Tachycardia
6.3.4. Others
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Hospitals & ASC’s
6.4.2. Specialty Clinics & Diagnostic Centers
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Type
7.2.1. Ablation Catheters
7.2.2. Diagnostic Catheters
7.2.3. Mapping System
7.2.4. Accessories
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Application
7.3.1. Atrial Fibrillation
7.3.2. Supraventricular Tachycardia (SVT)
7.3.3. Ventricular Tachycardia
7.3.4. Others
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Hospitals & ASC’s
7.4.2. Specialty Clinics & Diagnostic Centers
7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Type
8.2.1. Ablation Catheters
8.2.2. Diagnostic Catheters
8.2.3. Mapping System
8.2.4. Accessories
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Application
8.3.1. Atrial Fibrillation
8.3.2. Supraventricular Tachycardia (SVT)
8.3.3. Ventricular Tachycardia
8.3.4. Others
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Hospitals & ASC’s
8.4.2. Specialty Clinics & Diagnostic Centers
8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Type
9.2.1. Ablation Catheters
9.2.2. Diagnostic Catheters
9.2.3. Mapping System
9.2.4. Accessories
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Application
9.3.1. Atrial Fibrillation
9.3.2. Supraventricular Tachycardia (SVT)
9.3.3. Ventricular Tachycardia
9.3.4. Others
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Hospitals & ASC’s
9.4.2. Specialty Clinics & Diagnostic Centers
9.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Electrophysiology Devices Market Analysis, Insights and Forecast, 2019-2032
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Type
10.2.1. Ablation Catheters
10.2.2. Diagnostic Catheters
10.2.3. Mapping System
10.2.4. Accessories
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Application
10.3.1. Atrial Fibrillation
10.3.2. Supraventricular Tachycardia (SVT)
10.3.3. Ventricular Tachycardia
10.3.4. Others
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Hospitals & ASC’s
10.4.2. Specialty Clinics & Diagnostic Centers
10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2024)
11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
11.3.1. Abbott
11.3.1.1. Overview,
11.3.1.2. Products,
11.3.1.3. SWOT Analysis,
11.3.1.4. Recent Developments,
11.3.1.5. Strategies,
11.3.1.6. Financials (based on availability)
11.3.2. Medtronic
11.3.2.1. Overview,
11.3.2.2. Products,
11.3.2.3. SWOT Analysis,
11.3.2.4. Recent Developments,
11.3.2.5. Strategies,
11.3.2.6. Financials (based on availability)
11.3.3. Boston Scientific Corporation
11.3.3.1. Overview,
11.3.3.2. Products,
11.3.3.3. SWOT Analysis,
11.3.3.4. Recent Developments,
11.3.3.5. Strategies,
11.3.3.6. Financials (based on availability)
11.3.4. Johnson & Johnson Services, Inc.
11.3.4.1. Overview,
11.3.4.2. Products,
11.3.4.3. SWOT Analysis,
11.3.4.4. Recent Developments,
11.3.4.5. Strategies,
11.3.4.6. Financials (based on availability)
11.3.5. Stereotaxis, Inc.
11.3.5.1. Overview,
11.3.5.2. Products,
11.3.5.3. SWOT Analysis,
11.3.5.4. Recent Developments,
11.3.5.5. Strategies,
11.3.5.6. Financials (based on availability)
11.3.6. AngioDynamics
11.3.6.1. Overview,
11.3.6.2. Products,
11.3.6.3. SWOT Analysis,
11.3.6.4. Recent Developments,
11.3.6.5. Strategies,
11.3.6.6. Financials (based on availability)
11.3.7. Biotronik, Inc.
11.3.7.1. Overview,
11.3.7.2. Products,
11.3.7.3. SWOT Analysis,
11.3.7.4. Recent Developments,
11.3.7.5. Strategies,
11.3.7.6. Financials (based on availability)
11.3.8. Other Prominent Players
11.3.8.1. Overview,
11.3.8.2. Products,
11.3.8.3. SWOT Analysis,
11.3.8.4. Recent Developments,
11.3.8.5. Strategies,
11.3.8.6. Financials (based on availability)
12. Strategic Recommendations
Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 提供ファイル：PDF（印刷不可）
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート
